These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 29083488)

  • 21. Dendritic Cell-Specific Transmembrane Protein (DC-STAMP) Regulates Osteoclast Differentiation via the Ca
    Chiu YH; Schwarz E; Li D; Xu Y; Sheu TR; Li J; de Mesy Bentley KL; Feng C; Wang B; Wang JC; Albertorio-Saez L; Wood R; Kim M; Wang W; Ritchlin CT
    J Cell Physiol; 2017 Sep; 232(9):2538-2549. PubMed ID: 27723141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glaucocalyxin A suppresses osteoclastogenesis induced by RANKL and osteoporosis induced by ovariectomy by inhibiting the NF-κB and Akt pathways.
    Zhu M; Shan J; Xu H; Xia G; Xu Q; Quan K; Liu X; Dai M
    J Ethnopharmacol; 2021 Aug; 276():114176. PubMed ID: 33933570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA damage-inducible transcript 3 restrains osteoclast differentiation and function.
    Yang B; Sun H; Jia M; He Y; Luo Y; Wang T; Wu Y; Wang J
    Bone; 2021 Dec; 153():116162. PubMed ID: 34455116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-128 plays a critical role in murine osteoclastogenesis and estrogen deficiency-induced bone loss.
    Shen G; Ren H; Shang Q; Zhang Z; Zhao W; Yu X; Tang J; Yang Z; Liang D; Jiang X
    Theranostics; 2020; 10(10):4334-4348. PubMed ID: 32292498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. mTORC1 Inhibits NF-κB/NFATc1 Signaling and Prevents Osteoclast Precursor Differentiation, In Vitro and In Mice.
    Zhang Y; Xu S; Li K; Tan K; Liang K; Wang J; Shen J; Zou W; Hu L; Cai D; Ding C; Li M; Xiao G; Liu B; Liu A; Bai X
    J Bone Miner Res; 2017 Sep; 32(9):1829-1840. PubMed ID: 28520214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arctigenin inhibits osteoclast differentiation and function by suppressing both calcineurin-dependent and osteoblastic cell-dependent NFATc1 pathways.
    Yamashita T; Uehara S; Udagawa N; Li F; Kadota S; Esumi H; Kobayashi Y; Takahashi N
    PLoS One; 2014; 9(1):e85878. PubMed ID: 24465763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PU.1 and NFATc1 mediate osteoclastic induction of the mouse beta3 integrin promoter.
    Crotti TN; Sharma SM; Fleming JD; Flannery MR; Ostrowski MC; Goldring SR; McHugh KP
    J Cell Physiol; 2008 Jun; 215(3):636-44. PubMed ID: 18288635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dynein light chain LC8 inhibits osteoclast differentiation and prevents bone loss in mice.
    Kim H; Hyeon S; Kim H; Yang Y; Huh JY; Park DR; Lee H; Seo DH; Kim HS; Lee SY; Jeong W
    J Immunol; 2013 Feb; 190(3):1312-8. PubMed ID: 23293355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ASXL1 impairs osteoclast formation by epigenetic regulation of NFATc1.
    Rohatgi N; Zou W; Collins PL; Brestoff JR; Chen TH; Abu-Amer Y; Teitelbaum SL
    Blood Adv; 2018 Oct; 2(19):2467-2477. PubMed ID: 30266822
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-Osteoporotic Effects of Polysaccharides Isolated from Persimmon Leaves via Osteoclastogenesis Inhibition.
    Hwang YH; Ha H; Kim R; Cho CW; Song YR; Hong HD; Kim T
    Nutrients; 2018 Jul; 10(7):. PubMed ID: 30011853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Onc201 reduces osteoclastogenesis and prevents ovariectomy-induced bone loss via inhibiting RANKL-induced NFATc1 activation and the integrin signaling pathway.
    Wu L; Liang J; Li J; Xu Y; Chen J; Su Y; Xian Y; Wei J; Xu J; Zhao J; Liu Q; Yang Y
    Eur J Pharmacol; 2022 May; 923():174908. PubMed ID: 35405113
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The L-type amino acid transporter LAT1 inhibits osteoclastogenesis and maintains bone homeostasis through the mTORC1 pathway.
    Ozaki K; Yamada T; Horie T; Ishizaki A; Hiraiwa M; Iezaki T; Park G; Fukasawa K; Kamada H; Tokumura K; Motono M; Kaneda K; Ogawa K; Ochi H; Sato S; Kobayashi Y; Shi YB; Taylor PM; Hinoi E
    Sci Signal; 2019 Jul; 12(589):. PubMed ID: 31289211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. C/EBPα and PU.1 exhibit different responses to RANK signaling for osteoclastogenesis.
    Jules J; Li YP; Chen W
    Bone; 2018 Feb; 107():104-114. PubMed ID: 29032174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulatory mechanism of NFATc1 in RANKL-induced osteoclast activation.
    Song I; Kim JH; Kim K; Jin HM; Youn BU; Kim N
    FEBS Lett; 2009 Jul; 583(14):2435-40. PubMed ID: 19576893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trimethylamine-N-Oxide Promotes Osteoclast Differentiation and Bone Loss via Activating ROS-Dependent NF-κB Signaling Pathway.
    Wang N; Hao Y; Fu L
    Nutrients; 2022 Sep; 14(19):. PubMed ID: 36235607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Knockdown of TRPV4 suppresses osteoclast differentiation and osteoporosis by inhibiting autophagy through Ca
    Cao B; Dai X; Wang W
    J Cell Physiol; 2019 May; 234(5):6831-6841. PubMed ID: 30387123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myeloid-Specific PTP1B Deficiency Attenuates Inflammation-Induced and Ovariectomy-Induced Bone Loss in Mice by Inhibiting Osteoclastogenesis.
    Kim HJ; Ryu KY; Kim YG; Kim MO; Lee JH; Song MK; Youn YJ; Pokhrel NK; Kim SH; Kim JY; Jung HJ; Kim WS; Hong CW; Kim HH; Lee Y
    J Bone Miner Res; 2022 Mar; 37(3):505-514. PubMed ID: 34812548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ginsenoside Rb2 inhibits osteoclast differentiation through nuclear factor-kappaB and signal transducer and activator of transcription protein 3 signaling pathway.
    Cong F; Liu J; Wang C; Yuan Z; Bi L; Liang J; Su K; Qiu Y; Song T; Fan J; Chao G
    Biomed Pharmacother; 2017 Aug; 92():927-934. PubMed ID: 28605877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum calcium-decreasing factor, caldecrin, inhibits osteoclast differentiation by suppression of NFATc1 activity.
    Hasegawa H; Kido S; Tomomura M; Fujimoto K; Ohi M; Kiyomura M; Kanegae H; Inaba A; Sakagami H; Tomomura A
    J Biol Chem; 2010 Aug; 285(33):25448-57. PubMed ID: 20547767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apolipoprotein E plays crucial roles in maintaining bone mass by promoting osteoblast differentiation via ERK1/2 pathway and by suppressing osteoclast differentiation via c-Fos, NFATc1, and NF-κB pathway.
    Noguchi T; Ebina K; Hirao M; Otsuru S; Guess AJ; Kawase R; Ohama T; Yamashita S; Etani Y; Okamura G; Yoshikawa H
    Biochem Biophys Res Commun; 2018 Sep; 503(2):644-650. PubMed ID: 29906458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.